Back to Newsroom

Catalyst Pharmaceuticals Joins Russell 2000, 3000 and Global Indexes

CORAL GABLES, Fla., June 29, 2015 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today announced that the company has been added to the Russell 2000®, the Russell 3000® and Russell Global Indexes, following Russell’s annual reconstitution on June 26, according to a preliminary list of additions posted June 12, 2015 on the FTSE Russell website.

Click here to read more